Lisdexamfetamine dimesylate
-
Lisdexamfetamine dimesylate
structure -
-
CAS No:
608137-33-3
-
Formula:
C15H25N3O.2CH4O3S
-
Chemical Name:
Lisdexamfetamine dimesylate
-
Synonyms:
Hexanamide,2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl]-,(2S)-,methanesulfonate (1:2);Hexanamide,2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl]-,(2S)-,dimethanesulfonate;NRP 104;Lisdexamfetamine dimesylate;Vyvanse;SPD 489;N-(L-Lysyl)-D-amphetamine dimesylate;Lisdexamphetamine dimesylate
- Categories:
-
CAS No:
Description
Vyvanse is a DEA Schedule II controlled substance. Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence.|Lisdexamfetamine Dimesylate is the dimesylate form and prodrug of the d-isomer of amphetamine, a non-catecholamine sympathomimetic amine with central nervous system (CNS) stimulating activity. Upon administration, lisdexamphetamine is converted to dextroamphetamine through cleavage of the lysine group. Dextroamphetamine acts by facilitating the release of catecholamines, particularly noradrenaline and dopamine, from its storage sites in nerve terminals in the CNS, and inhibits their uptake within the mesocorticolimbic system, a major component of the brain reward system, resulting in measurable behavioral changes such as euphoria, mental alertness and excitement and appetite suppression. As a CNS stimulant, this agent may increase blood pressure.|A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.
Lisdexamfetamine dimesylate Basic Attributes
455.58982
455.17600
200-659-6
SJT761GEGS
1205
DTXSID60209653
C76628
Safety Information
UN1230 - class 3 - PG 2 - Methanol, solution
1
11-23/24/25-39/23/24/25
7-16-36/37-45
F,T
P210-P260-P280-P301 + P310-P311
H225-H301 + H311 + H331-H370
Drug Information
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)|Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)
Dimesylate, Lis-dexamfetamine
Lisdexamfetamine|Vyvanse|1205|Schedule II - Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence.|No
Lisdexamfetamine dimesylate Use and Manufacturing
Treatment of atten tion deficit hyperactivity disorder (ADHD).
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:455.6
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:9
Rotatable Bond Count:8
Exact Mass:455.17599275
Monoisotopic Mass:455.17599275
Topological Polar Surface Area:207
Heavy Atom Count:29
Complexity:344
Defined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:3
Compound Is Canonicalized:Yes
Recommended Suppliers of Lisdexamfetamine dimesylate
-
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Custom Synthetic Chemicals,Biological Stains,Pharmaceutical Intermediates,Cosmetic Grade Chemicals,Enzyme,Nucleosides,Indicators,Speciality Chemicals,Biological Chemicals,Enzyme Substrates
Learn More Other Chemicals
-
Bisnafide dimesylate
145124-30-7
-
L-Cysteine
52-90-4
-
1-chloro-6-Methyl-5-nitroisoquinoline
943606-84-6
-
2-chloro-N-(2-oxothiolan-3-yl)acetamide Formula
84611-22-3
-
N-[(Phenylmethoxy)carbonyl]-L-phenylalanylglycine Formula
13122-99-1
-
(αR)-α-[(Methoxycarbonyl)amino]benzeneacetic acid Formula
50890-96-5
-
3,4,5-Trimethoxy-N-(2-methoxyethyl)-N-(4-phenyl-2-thiazolyl)-benzamide Structure
461000-66-8
-
5-(4-Hydroxyphenyl)-2,4-imidazolidinedione Structure
2420-17-9
-
What is γ-Aminobenzenepropanol
14593-04-5
-
What is tert-Butyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate
170491-63-1